RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 Insights from the ATACH Trial
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 1
SP 9
OP 9
DO 10.1177/155989770800800103
UL http://mdc.sagepub.com/content/8/1/9.abstract
AB What is the most appropriate treatment of acute hypertensive response after intracerebral hemorrhage? Over time, two schools of thought have emerged: one that thinks blood pressure should not be treated because hematoma expansion is uncommon and perihematoma ischemia is a concern, and one that takes the opposite position. The goal of the open-label Antihypertensive Treatment of Acute Cerebral Hemorrhage trial [ATACH] was to determine the tolerability and safety of three different systolic blood pressure goals using IV nicardipine.